×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Exchange
/
Hypotheses
🧪 Hypotheses
155 hypotheses generated by SciDEX — searchable by gene, disease, or keyword
155
Total Hypotheses
0.65
Avg Score
0.56
Avg Feasibility
Search
All
therapeutic (155)
mechanistic (0)
diagnostic (0)
methodological (0)
All Diseases
Alzheimer's Disease
Alzheimer's disease
molecular biology
neurodegeneration
neuroinflammation
neuropharmacology
neuroscience
Sort:
Score
Feasibility
Novelty
Impact
Newest
therapeutic
1.00
APOE4-Specific Lipidation Enhancement Therapy
🧬 APOE
🏥 Alzheimer's disease
✅ 0.00
✨ 0.00
💥 0.00
## Molecular Mechanism and Rationale...
therapeutic
0.94
Metabolic Reprogramming to Reverse Senescence
🧬 SIRT1,PGC1A,NAMPT
🏥 N/A
✅ 0.90
✨ 0.60
💥 0.00
# Metabolic Reprogramming to Reverse Senescence in Neurodegeneration: A Mechanistic Hypothesis...
therapeutic
0.91
Closed-loop focused ultrasound targeting EC-II SST interneurons to restore gamma gating and block tau propagation in AD
🧬 SST
🏥 Alzheimer's disease
✅ 0.87
✨ 0.79
💥 0.81
## Molecular Mechanism and Rationale...
therapeutic
0.90
Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and restore perforant-path gamma gating in AD
🧬 SST
🏥 Alzheimer's disease
✅ 0.86
✨ 0.78
💥 0.82
## Molecular Mechanism and Rationale...
therapeutic
0.89
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization
🧬 BDNF
🏥 Alzheimer's disease
✅ 0.70
✨ 0.82
💥 0.83
## Molecular Mechanism and Rationale...
therapeutic
0.88
LRP1-Dependent Tau Uptake Disruption
🧬 LRP1
🏥 neurodegeneration
✅ 0.00
✨ 0.00
💥 0.00
# LRP1-Dependent Tau Uptake Disruption in Tauopathic Neurodegeneration...
therapeutic
0.87
SASP Modulation Rather Than Cell Elimination
🧬 NFKB1,IL1B,BDNF
🏥 N/A
✅ 0.80
✨ 0.70
💥 0.00
# SASP Modulation Rather Than Cell Elimination...
therapeutic
0.87
Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagation via perforant path i
🧬 PVALB
🏥 Alzheimer's disease
✅ 0.87
✨ 0.78
💥 0.81
## Molecular Mechanism and Rationale...
therapeutic
0.87
Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance
🧬 SST
🏥 Alzheimer's disease
✅ 0.85
✨ 0.82
💥 0.82
## Molecular Mechanism and Rationale...
therapeutic
0.86
Selective Acid Sphingomyelinase Modulation Therapy
🧬 SMPD1
🏥 neurodegeneration
✅ 0.90
✨ 0.70
💥 0.85
**Overview**...
therapeutic
0.86
Palmitoylethanolamide-Based Endocannabinoid Therapy
🧬 PPARA
🏥 N/A
✅ 0.00
✨ 0.00
💥 0.00
**Background and Rationale**...
therapeutic
0.85
Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and block tau AIS disruption i
🧬 PVALB
🏥 Alzheimer's disease
✅ 0.86
✨ 0.79
💥 0.80
## Molecular Mechanism and Rationale...
therapeutic
0.84
CYP46A1 Overexpression Gene Therapy
🧬 CYP46A1
🏥 neurodegeneration
✅ 0.60
✨ 0.95
💥 0.90
**CYP46A1 Overexpression Gene Therapy for Alzheimer's Disease**...
therapeutic
0.84
Dual-Receptor Antibody Shuttling
🧬 N/A
🏥 Alzheimer's disease
✅ 0.00
✨ 0.00
💥 0.00
# Dual-Receptor Antibody Shuttling: A Strategic Approach to Overcoming Blood-Brain Barrier Limitations in Neurodegenerative Disease Therapy...
therapeutic
0.83
Autophagy-Senescence Axis Therapeutic Window
🧬 ATG7,BCL2,BCL2L1
🏥 N/A
✅ 0.60
✨ 0.80
💥 0.00
# Autophagy-Senescence Axis Therapeutic Window: Sequential Targeting of ATG7 and BCL-2 Family Proteins in Neurodegeneration...
therapeutic
0.82
APOE-Dependent Autophagy Restoration
🧬 MTOR
🏥 neurodegeneration
✅ 0.90
✨ 0.60
💥 0.80
APOE-Dependent Autophagy Restoration proposes targeting the mechanistic link between apolipoprotein E4 (APOE4) genotype and impaired macroautophagy as...
therapeutic
0.82
Closed-loop transcranial alternating current stimulation to restore hippocampal-prefrontal gamma synchrony via PV intern
🧬 SST
🏥 Alzheimer's disease
✅ 0.88
✨ 0.78
💥 0.81
## Molecular Mechanism and Rationale...
therapeutic
0.81
Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation
🧬 HCRTR1/HCRTR2
🏥 neurodegeneration
✅ 0.90
✨ 0.75
💥 0.80
**Overview**...
therapeutic
0.80
Closed-loop focused ultrasound targeting CA1 PV interneurons to restore theta-gamma coupling and block synaptotoxic Aβ o
🧬 PVALB
🏥 Alzheimer's disease
✅ 0.65
✨ 0.88
💥 0.78
## Molecular Mechanism and Rationale...
therapeutic
0.80
Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to prevent tau propagation and restore ento
🧬 SST
🏥 Alzheimer's disease
✅ 0.45
✨ 0.90
💥 0.80
## Molecular Mechanism and Rationale...
therapeutic
0.78
Senescence-Activated NAD+ Depletion Rescue
🧬 CD38/NAMPT
🏥 neurodegeneration
✅ 0.70
✨ 0.75
💥 0.75
**Molecular Mechanism and Rationale**...
therapeutic
0.77
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming
🧬 TLR4
🏥 neurodegeneration
✅ 0.80
✨ 0.70
💥 0.70
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming proposes targeting the Toll-like receptor 4 (TLR4) signaling axis as the cr...
therapeutic
0.77
AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses
🧬 PRKAA1
🏥 neurodegeneration
✅ 0.85
✨ 0.80
💥 0.75
**AMPK Hypersensitivity Engineering for Neuroprotection: Astrocyte-Mediated Mitochondrial Rescue**...
therapeutic
0.77
Prefrontal sensory gating circuit restoration via PV interneuron enhancement
🧬 PVALB
🏥 Alzheimer's disease
✅ 0.70
✨ 0.72
💥 0.73
## Molecular Mechanism and Rationale...
therapeutic
0.76
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal
🧬 CYP46A1
🏥 neurodegeneration
✅ 0.60
✨ 0.75
💥 0.80
## Molecular Mechanism and Rationale...
therapeutic
0.76
Selective Neutral Sphingomyelinase-2 Inhibition Therapy
🧬 SMPD3
🏥 neurodegeneration
✅ 0.00
✨ 0.00
💥 0.00
This hypothesis proposes selective pharmacological inhibition of neutral sphingomyelinase-2 (nSMase2, encoded by SMPD3) to prevent pathological cerami...
therapeutic
0.75
Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibition and block tau propagation in AD
🧬 PVALB
🏥 Alzheimer's disease
✅ 0.65
✨ 0.78
💥 0.75
## Molecular Mechanism and Rationale...
therapeutic
0.75
Neutrophil Extracellular Trap (NET) Inhibition
🧬 PADI4
🏥 N/A
✅ 0.00
✨ 0.00
💥 0.00
**Background and Rationale**...
therapeutic
0.75
Circadian-Synchronized Proteostasis Enhancement
🧬 CLOCK/ULK1
🏥 neurodegeneration
✅ 0.60
✨ 0.80
💥 0.70
# Detailed Scientific Description: Circadian-Synchronized Proteostasis Enhancement...
therapeutic
0.75
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modulation
🧬 FCGRT
🏥 neurodegeneration
✅ 0.70
✨ 0.60
💥 0.60
**Molecular Mechanism and Rationale**...
Loading more hypotheses...
All 155 hypotheses loaded